Skip to main content
Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexity.
In Utero Hematopoietic Cell Transplantation in Fetuses with Alpha Thalassemia Major: A Phase 1 Clinical Trial.
Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy Trials.
TLR8 gain-of-function: on the highway to the danger zone.
American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic Anemia.
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study.
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL.
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC.
Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1.